{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T05:34:36Z","timestamp":1788068076840,"version":"build-2784847793"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002089","name":"Fight for Sight","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001734","name":"K\u00f8benhavns Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.eclinm.2021.101248","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T23:35:20Z","timestamp":1640388920000},"page":"101248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Patients with MPNs and retinal drusen show signs of complement system dysregulation and a high degree of chronic low-grade inflammation"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6353-6027","authenticated-orcid":false,"given":"Charlotte","family":"Liisborg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibe","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Carl","family":"Hasselbalch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben Lykke","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2021.101248_bib0001","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.eclinm.2021.101248_bib0002","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","article-title":"Age-related macular degeneration","volume":"392","author":"Mitchell","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2021.101248_bib0003","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00417-010-1568-6","article-title":"The significance of the complement system for the pathogenesis of age-related macular degeneration \u2014 Current evidence and translation into clinical application","volume":"249","author":"Charbel Issa","year":"2011","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/7532507","article-title":"Complement System and Age-Related Macular Degeneration: implications of Gene-Environment Interaction for Preventive and Personalized Medicine","volume":"2018","author":"Maugeri","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.eclinm.2021.101248_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.100825","article-title":"Age-related macular degeneration: a two-level model hypothesis","volume":"76","author":"Rozing","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.eclinm.2021.101248_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2011.02.017","article-title":"Implication of CD21, CD35, and CD55 in the pathogenesis of age-related macular degeneration","volume":"152","author":"Haas","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0007","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.2147\/DDDT.S206355","article-title":"Complement system and age-related macular degeneration: drugs and challenges","volume":"13","author":"Wu","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.eclinm.2021.101248_bib0008","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.molimm.2016.11.016","article-title":"The complement system in age-related macular degeneration: a review of rare genetic variants and implications for personalized treatment","volume":"84","author":"Geerlings","year":"2017","journal-title":"Mol Immunol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0009","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.preteyeres.2009.11.003","article-title":"The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited","volume":"29","author":"Anderson","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.eclinm.2021.101248_bib0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molimm.2015.02.032","article-title":"Age-related macular degeneration and the role of the complement system","volume":"67","author":"Mcharg","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0011","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.imbio.2011.07.019","article-title":"Age-related macular degeneration and the complement system","volume":"217","author":"Khandhadia","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.eclinm.2021.101248_bib0012","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.1167\/iovs.12-9587","article-title":"Activation of the alternative complement pathway in vitreous is controlled by genetics in age-related macular degeneration","volume":"53","author":"Loyet","year":"2012","journal-title":"Investig Opthalmology Vis Sci"},{"key":"10.1016\/j.eclinm.2021.101248_bib0013","doi-asserted-by":"crossref","first-page":"e2593","DOI":"10.1371\/journal.pone.0002593","article-title":"Systemic complement activation in age-related macular degeneration","volume":"3","author":"Scholl","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.eclinm.2021.101248_bib0014","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1167\/iovs.09-3928","article-title":"Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes","volume":"50","author":"Reynolds","year":"2009","journal-title":"Investig Opthalmology Vis Sci"},{"key":"10.1016\/j.eclinm.2021.101248_bib0015","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cll.2019.07.006","article-title":"Analysis of the complement system in the clinical immunology laboratory","volume":"39","author":"Ling","year":"2019","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.eclinm.2021.101248_bib0016","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/joim.12606","article-title":"The role of complement inhibitors beyond controlling inflammation","volume":"282","author":"Blom","year":"2017","journal-title":"J Intern Med"},{"key":"10.1016\/j.eclinm.2021.101248_bib0017","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1172\/JCI29251","article-title":"Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis","volume":"116","author":"Astier","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.eclinm.2021.101248_bib0018","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2567.2008.02821.x","article-title":"T-cell regulation by CD46 and its relevance in multiple sclerosis","volume":"124","author":"Astier","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.eclinm.2021.101248_bib0019","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/eji.201646822","article-title":"Dysregulated CD46 shedding interferes with Th1-contraction in systemic lupus erythematosus","volume":"47","author":"Ellinghaus","year":"2017","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajo.2012.01.036","article-title":"Altered expression of CD46 and CD59 on leukocytes in neo-vascular age-related macular degeneration","volume":"154","author":"Singh","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0021","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0002-9394(02)01624-0","article-title":"A role for local inflammation in the formation of drusen in the aging eye","volume":"134","author":"Anderson","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0022","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1073\/pnas.0501536102","article-title":"A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration","volume":"102","author":"Hageman","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.eclinm.2021.101248_bib0023","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1096\/fasebj.14.7.835","article-title":"Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease","volume":"14","author":"Mullins","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.eclinm.2021.101248_bib0024","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-4419-5635-4_3","article-title":"Multiple interactions of complement factor H with its ligands in solution: a progress report","volume":"703","author":"Perkins","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100526","article-title":"Patients with myeloproliferative neoplasms and high levels of systemic inflammation develop age-related macular degeneration","volume":"26","author":"Liisborg","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.eclinm.2021.101248_bib0026","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jamaophthalmol.2017.2011","article-title":"Age-related macular degeneration in patients with chronic myeloproliferative neoplasms","volume":"135","author":"Bak","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0027","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1056\/NEJMra1406186","article-title":"Myeloproliferative neoplasms","volume":"376","author":"Spivak","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2021.101248_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/102476","article-title":"MPNs as inflammatory diseases: the evidence, consequences, and perspectives","volume":"2015","author":"Hasselbalch","year":"2015","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.eclinm.2021.101248_bib0029","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.leukres.2012.10.020","article-title":"Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?","volume":"37","author":"Hasselbalch","year":"2013","journal-title":"Leuk Res"},{"key":"10.1016\/j.eclinm.2021.101248_bib0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cytogfr.2013.01.004","article-title":"The role of cytokines in the initiation and progression of myelofibrosis","volume":"24","author":"Hasselbalch","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.eclinm.2021.101248_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0183620","article-title":"Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development","volume":"12","author":"Andersen","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.eclinm.2021.101248_bib0032","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood-2011-11-394775","article-title":"Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?","volume":"119","author":"Hasselbalch","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.eclinm.2021.101248_bib0033","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12974-020-01877-3","article-title":"Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer's disease: evidences and perspectives","volume":"17","author":"Hasselbalch","year":"2020","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.eclinm.2021.101248_bib0034","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration","volume":"12","author":"Vandenbroucke","year":"2014","journal-title":"Int J Surg"},{"key":"10.1016\/j.eclinm.2021.101248_bib0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41408-018-0054-y","article-title":"The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion","volume":"8","author":"Barbui","year":"2018","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.eclinm.2021.101248_bib0036","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0161-6420(91)32186-9","article-title":"The Wisconsin age-related maculopathy grading system","volume":"98","author":"Klein","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.eclinm.2021.101248_bib0037","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/ceo.13152","article-title":"Altered proportion of CCR2 + and CX3CR1 + circulating monocytes in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"46","author":"Subhi","year":"2018","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0038","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1167\/iovs.17-22479","article-title":"CD11b and CD200 on circulating monocytes differentiate two angiographic subtypes of polypoidal choroidal vasculopathy","volume":"58","author":"Subhi","year":"2017","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.eclinm.2021.101248_bib0039","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/ceo.13362","article-title":"Patients with a fast progression profile in geographic atrophy have increased CD200 expression on circulating monocytes","volume":"47","author":"Krogh Nielsen","year":"2019","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0040","doi-asserted-by":"crossref","first-page":"14829","DOI":"10.1038\/s41598-019-51339-x","article-title":"Hydroxyurea alters circulating monocyte subsets and dampens its inflammatory potential in sickle cell anemia patients","volume":"9","author":"Guarda","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.eclinm.2021.101248_bib0041","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1006\/exer.1999.0798","article-title":"A potential role for immune complex pathogenesis in drusen formation","volume":"70","author":"Johnson","year":"2000","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.eclinm.2021.101248_bib0042","doi-asserted-by":"crossref","first-page":"16182","DOI":"10.1073\/pnas.0604255103","article-title":"Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium","volume":"103","author":"Zhou","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.eclinm.2021.101248_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101339","article-title":"Complement activation and regulation in rheumatic disease","volume":"45","author":"Dijkstra","year":"2019","journal-title":"Semin Immunol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0044","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.molimm.2019.07.031","article-title":"Role of complement in diabetes","volume":"114","author":"Ajjan","year":"2019","journal-title":"Mol Immunol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0045","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1136\/annrheumdis-2014-205287","article-title":"The complement system in systemic lupus erythematosus: an update","volume":"73","author":"Leffler","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.eclinm.2021.101248_bib0046","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.atherosclerosis.2015.05.038","article-title":"The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis","volume":"241","author":"Hovland","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.eclinm.2021.101248_bib0047","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1172\/JCI90962","article-title":"The role of the complement system in cancer","volume":"127","author":"Afshar-Kharghan","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.eclinm.2021.101248_bib0048","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.semcdb.2017.11.023","article-title":"Complement anaphylatoxins C3a and C5a: emerging roles in cancer progression and treatment","volume":"85","author":"Ajona","year":"2019","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0049","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12959-021-00269-8","article-title":"JAK2V617F positive polycythemia vera with paroxysmal nocturnal hemoglobinuria and visceral thromboses: a case report and review of the literature","volume":"19","author":"Chatzidavid","year":"2021","journal-title":"Thromb J"},{"key":"10.1016\/j.eclinm.2021.101248_bib0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1034\/j.1600-0609.2000.80097.x","article-title":"Expression of complement regulatory proteins CR1, DAF, MCP and CD59in haematological malignancies","volume":"64","author":"Guc","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0051","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood.V58.5.904.904","article-title":"Immunologic abnormalities in myelofibrosis with activation of the complement system","volume":"58","author":"Gordon","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.eclinm.2021.101248_bib0052","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071792","article-title":"Components of the lectin pathway of complement in haematologic malignancies","volume":"12","author":"Cedzy\u0144ski","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.eclinm.2021.101248_bib0053","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1167\/iovs.08-3202","article-title":"Expression and modulation of RPE cell membrane complement regulatory proteins","volume":"50","author":"Yang","year":"2009","journal-title":"Investig Opthalmology Vis Sci"},{"key":"10.1016\/j.eclinm.2021.101248_bib0054","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.1110359","article-title":"Complement factor H variant increases the risk of age-related macular degeneration","volume":"308","author":"Haines","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.eclinm.2021.101248_bib0055","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration","volume":"308","author":"Edwards","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.eclinm.2021.101248_bib0056","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.eclinm.2021.101248_bib0057","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ng1871","article-title":"CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration","volume":"38","author":"Li","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.eclinm.2021.101248_bib0058","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1167\/iovs.16-20867","article-title":"Systematic functional testing of rare variants: contributions of CFI to age-related macular degeneration","volume":"58","author":"Tan","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.eclinm.2021.101248_bib0059","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/ng.2758","article-title":"Identification of a rare coding variant in complement 3 associated with age-related macular degeneration","volume":"45","author":"Zhan","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.eclinm.2021.101248_bib0060","doi-asserted-by":"crossref","first-page":"e5304","DOI":"10.1371\/journal.pone.0005304","article-title":"Changes in retinal pigment epithelium related to cigarette smoke: possible relevance to smoking as a risk factor for age-related macular degeneration","volume":"4","author":"Wang","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.eclinm.2021.101248_bib0061","doi-asserted-by":"crossref","first-page":"16939","DOI":"10.1074\/jbc.M808166200","article-title":"Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury","volume":"284","author":"Thurman","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.eclinm.2021.101248_bib0062","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2010.12.016","article-title":"The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization","volume":"48","author":"Rohrer","year":"2011","journal-title":"Mol Immunol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0063","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/archopht.125.4.515","article-title":"Estimation of systemic complement C3 activity in age-related macular degeneration","volume":"125","author":"Sivaprasad","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0064","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000219686","article-title":"Elevated plasma levels of C3a complement compound in the exudative form of age-related macular degeneration","volume":"42","author":"Machali\u0144ska","year":"2009","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.eclinm.2021.101248_bib0065","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1167\/iovs.12-10385","article-title":"Complement factor H deficiency results in decreased neuroretinal expression of Cd59a in aged mice","volume":"53","author":"Faber","year":"2012","journal-title":"Investig Opthalmology Vis Sci"},{"key":"10.1016\/j.eclinm.2021.101248_bib0066","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.4049\/jimmunol.178.3.1783","article-title":"CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration","volume":"178","author":"Bora","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0067","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4049\/jimmunol.174.1.491","article-title":"Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization","volume":"174","author":"Bora","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0068","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molimm.2019.11.007","article-title":"Complement receptor 1 (CR1\/CD35)-expressing retinal pigment epithelial cells as a potential therapy for age-related macular degeneration","volume":"118","author":"Simmons","year":"2020","journal-title":"Mol Immunol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0069","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1167\/iovs.13-11821","article-title":"Fc\u03b3 receptor upregulation is associated with immune complex inflammation in the mouse retina and early age-related macular degeneration","volume":"55","author":"Murinello","year":"2014","journal-title":"Investig Opthalmology Vis Sci"},{"key":"10.1016\/j.eclinm.2021.101248_bib0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2141.1981.tb07192.x","article-title":"Idiopathic myelofibrosis: a possible role for immune-complexes in the pathogenesis of bone marrow fibrosis","volume":"49","author":"Cappio","year":"1981","journal-title":"Br J Haematol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0071","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2141.1978.tb01093.x","article-title":"Immune complexes in myelofibrosis: a possible guide to management","volume":"39","author":"Lewis","year":"1978","journal-title":"Br J Haematol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0072","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1600-0609.1985.tb02252.x","article-title":"Circulating immune complexes in myelofibrosis","volume":"34","author":"Hasselbalch","year":"1985","journal-title":"Scand J Haematol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0073","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2257.1982.tb00073.x","article-title":"A study of the cellular and humoral immune response in patients with myelofibrosis","volume":"4","author":"Vellenga","year":"1982","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0074","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.exer.2011.06.015","article-title":"Elevated membrane attack complex in human choroid with high risk complement factor H genotypes","volume":"93","author":"Mullins","year":"2011","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.eclinm.2021.101248_bib0075","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1016\/j.ajpath.2014.07.017","article-title":"The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning","volume":"184","author":"Mullins","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0076","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0014-4835(02)00332-9","article-title":"Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration","volume":"76","author":"Gupta","year":"2003","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.eclinm.2021.101248_bib0077","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1172\/JCI31692","article-title":"CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration","volume":"117","author":"Combadi\u00e8re","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.eclinm.2021.101248_bib0078","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/emmm.201302692","article-title":"CCR 2\u00a0+\u00a0monocytes infiltrate atrophic lesions in age-related macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx3cr1 deficient mice","volume":"5","author":"Sennlaub","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.eclinm.2021.101248_bib0079","doi-asserted-by":"crossref","first-page":"211","DOI":"10.15252\/emmm.201404524","article-title":"Apolipoprotein E promotes subretinal mononuclear phagocyte survival and chronic inflammation in age-related macular degeneration","volume":"7","author":"Levy","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.eclinm.2021.101248_bib0080","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.preteyeres.2017.06.002","article-title":"On phagocytes and macular degeneration","volume":"61","author":"Guillonneau","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.eclinm.2021.101248_bib0081","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00417-015-3094-z","article-title":"Abundance of infiltrating CD163+ cells in the retina of postmortem eyes with dry and neovascular age-related macular degeneration","volume":"253","author":"Lad","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0082","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12026-012-8297-3","article-title":"The three human monocyte subsets: implications for health and disease","volume":"53","author":"Wong","year":"2012","journal-title":"Immunol Res"},{"key":"10.1016\/j.eclinm.2021.101248_bib0083","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1177\/1120672119857896","article-title":"Systemic activation of the complement system in patients with advanced age-related macular degeneration","volume":"30","author":"Lynch","year":"2020","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0084","first-page":"79","article-title":"Association of age-related macular degeneration with complement activation products, smoking, and single nucleotide polymorphisms in South Carolinians of European and African descent","volume":"25","author":"Rohrer","year":"2019","journal-title":"Mol Vis"},{"key":"10.1016\/j.eclinm.2021.101248_bib0085","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1111\/aos.13849","article-title":"The association between complement factor H rs1061170 polymorphism and age-related macular degeneration: a comprehensive meta-analysis stratified by stage of disease and ethnicity","volume":"97","author":"Maugeri","year":"2019","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0086","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/aje\/kwr025","article-title":"Systematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysis","volume":"173","author":"Thakkinstian","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.eclinm.2021.101248_bib0087","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1167\/iovs.08-3231","article-title":"Complement component 3 (C3) haplotypes and risk of advanced age-related macular degeneration","volume":"50","author":"Park","year":"2009","journal-title":"Investig Opthalmol Vis Sci"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537021005290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537021005290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:08:31Z","timestamp":1762888111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537021005290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":87,"alternative-id":["S2589537021005290"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.101248","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients with MPNs and retinal drusen show signs of complement system dysregulation and a high degree of chronic low-grade inflammation","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.101248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101248"}}